DARA Biosciences Inc. (DARA) News

News for DARA Biosciences Inc. (DARA)

Wed, Jan 18, 2012

8:45 AM

DARA BioSciences Signs Definitive Agreement to Raise $1.7 Million in Registered Direct Offering - Globe Newswire

Tue, Jan 17, 2012

8:45 AM

DARA BioSciences Announces Acquisition of U.S. Marketing Rights to Soltamox(TM), an FDA Approved Liquid Formulation of Tamoxifen for the Treatment of Breast Cancer - Globe Newswire

Tue, Dec 20, 2011

8:45 AM

DARA BioSciences Reports Appointment of Steve Gorlin as a Director and Designation of David J. Drutz as President and Chief Executive Officer - Globe Newswire

Wed, Dec 07, 2011

8:45 AM

DARA BioSciences Reports Management Changes - Globe Newswire

Tue, Nov 08, 2011

8:00 AM

Five New U.S. and Foreign Patents Have Been Granted to DARA BioSciences, Inc. - Globe Newswire

Wed, Nov 02, 2011

8:00 AM

DARA BioSciences Selected to Present at Conferences - Globe Newswire

Tue, Nov 01, 2011

8:00 AM

DARA BioSciences Announces Positive Results From a Successfully Completed Phase 1b Clinical Study of DB959 for the Treatment of Type 2 Diabetes - Globe Newswire

Mon, Oct 10, 2011

11:04 AM

KRN5500 Demonstrated Significant Decrease in the Intensity of Neuropathic Pain in Patients with Cancer, According to Findings Published in the Journal of Pain and Symptom Management - Globe Newswire

Thu, Sep 15, 2011

9:00 AM

DARA BioSciences Selected to Present the Positive Results of KRN5500 Phase 2 Study at the 5th Annual Therapeutics Summit - Globe Newswire

Tue, Sep 06, 2011

9:00 AM

DARA BioSciences to Present at Rodman & Renshaw Annual Global Healthcare Investment Conference - Globe Newswire

Thu, Aug 18, 2011

9:03 AM

DARA BioSciences Receives Fast Track Designation From the U.S. FDA for KRN5500 for the Treatment of Chemotherapy-Induced Neuropathic Pain in Patients With Cancer - Globe Newswire

Tue, Aug 16, 2011

9:00 AM

DARA BioSciences Files Quarterly Report With the SEC and Issues Overview of First Six Months - Globe Newswire

Tue, Jun 28, 2011

8:45 AM

DARA BioSciences Presented Positive Results of Its Phase I Study for DB959 at the American Diabetes Association Scientific Session - Globe Newswire

Tue, Jun 21, 2011

8:45 AM

DARA BioSciences to Present Positive Results of DB959 Phase I Study at the Upcoming 71st ADA Scientific Sessions - Globe Newswire

Tue, May 03, 2011

8:30 AM

DARA BioSciences Secures Additional Intellectual Property - Globe Newswire

Thu, Apr 21, 2011

8:31 AM

DARA BioSciences Selected by the American Diabetes Association to Present Results of DB959 Phase I Study at the Upcoming 71st ADA Scientific Sessions - Globe Newswire

Wed, Apr 20, 2011

2:43 PM

8th Annual Taglich Brothers Small Cap Equity Conference - Marketwire

Tue, Apr 19, 2011

8:30 AM

DARA BioSciences Reports SurgiVision has Received FDA Clearance for Its MRI-Compatible SmartFlow Cannula - Globe Newswire

Thu, Apr 14, 2011

8:30 AM

DARA BioSciences to Present at Three Financial Conferences in May - Globe Newswire

Tue, Apr 12, 2011

8:30 AM

DARA BioSciences Reports That SurgiVision Has Completed a Commercial Alliance With Brainlab AG - Globe Newswire

Thu, Apr 07, 2011

8:30 AM

DARA BioSciences Files 2010 Annual Report and Issues Overview - Globe Newswire

Tue, Apr 05, 2011

11:00 AM

DARA Biosciences, Inc. to Present at Taglich Brothers 8th Annual Small Cap Equity Conference - Marketwire

8:30 AM

DARA BioSciences Initiates a Phase Ib Clinical Study of DB959 for the Treatment of Type 2 Diabetes - Globe Newswire

Tue, Mar 29, 2011

8:30 AM

Report From Results of a Successful Phase II Study for DARA's KRN5500 at ADEPT - Globe Newswire

Fri, Mar 25, 2011

4:45 PM

DARA BioSciences Filing Shelf Registration Statement to Replace Expiring Registration Statement - Globe Newswire

First

1 2

Last